The analyst on the CC was merely trying to shake down JP for some early hints about IDIX’s HCV protease inhibitor. JP replied that abstracts about this drug will be submitted to the EASL conference to be held in April 2008.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”